Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-22-001632

10% owner bought 47,410 shares at an average $4.82 ($228,529)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cambrian BioPharma Inc 10% owner 2022-01-21 Purchase +24,703 $4.94 $122,033 5,040,579 D: show line 1 in the form
Cambrian BioPharma Inc 10% owner 2022-01-24 Purchase +22,707 $4.69 $106,496 5,063,286 D: show line 2 in the form
Open-market purchases · 47,410 sh · avg $4.82 · $228,529
Loading xslF345X03/doc1.xml…